Kura Oncology: Funding, Investors & Team (Sep 2026)
Kura Oncology is a biopharmaceutical business in the clinical stages dedicated on achieving the potential of precision medicines for the treatment of cancer. Our small-molecule therapeutic candidates focus on signaling pathways and other cancer-causing factors since there is a compelling clinical and scientific case for doing so in order to enhance outcomes by determining which patients will respond best to treatment. Tipifarnib, a farnesyl transferase inhibitor, is presently undergoing a registration-directed clinical trial, and KO-539, a menin-MLL inhibitor, is presently through a Phase 1/2A clinical trial. Both of these drugs are in our pipeline. Please visit our website at www.kuraoncology.com for further details.
Kura Oncology has raised $275M across 2 funding rounds on record, the most recent an undisclosed round of $150M announced in Jan 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kura Oncology Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Kura Oncology Funding Rounds
Kura Oncology raised $125M in an undisclosed round announced in Nov 2022.
1.2 years later, an undisclosed round of $150M was announced in Jan 2024.
Kura Oncology Founders and Leadership Team
Contact details for the Kura Oncology team: 1 of 1 has an email address on file.
Start 14-day free trial →Kura Oncology Funding Compared to Other Biotechnology Startups
Kura Oncology's latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kura Oncology in Biotechnology and La Jolla
Companies Similar to Kura Oncology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Kura Oncology Funding FAQs
What does Kura Oncology do?
Kura Oncology is a biopharmaceutical business in the clinical stages dedicated on achieving the potential of precision medicines for the treatment of cancer. Our small-molecule therapeutic candidates focus on signaling pathways and other cancer-causing factors since there is a compelling clinical and scientific case for doing so in order to enhance outcomes by determining which patients will respond best to treatment. Tipifarnib, a farnesyl transferase inhibitor, is presently undergoing a registration-directed clinical trial, and KO-539, a menin-MLL inhibitor, is presently through a Phase 1/2A clinical trial. Both of these drugs are in our pipeline. Please visit our website at www.kuraoncology.com for further details.
How much funding has Kura Oncology raised?
Kura Oncology has raised $275M across 2 rounds on record. The most recent is an undisclosed round of $150M announced in Jan 2024.
When did Kura Oncology last raise funding?
Kura Oncology's most recent funding round on record is an undisclosed round of $150M, announced in Jan 2024.
Who founded Kura Oncology?
FundedIQ lists Troy Wilson (Founder) at Kura Oncology.
Where is Kura Oncology headquartered?
Kura Oncology is based in La Jolla, California, United States.
How many employees does Kura Oncology have?
Kura Oncology is in the 101-250 employee band.
How does Kura Oncology's funding compare to other Biotechnology startups?
Kura Oncology's latest round of $150M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Kura Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kura Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.